AbbVie Raises 2019 Profit Target
Despite concerns about potential competition from recently approved and available European biosimilars to Humira, AbbVie was able to stave off some of the losses expected during Q2 2019.
Featured Posts
2015 U.S. trends in aggregate spend, disclosure, and transparency
What are key trends in the transparency compliance landscape? And, how are life sciences manufacturers tackling growing requirements
Johnson & Johnson to test experimental HIV vaccine in U.S., Europe
Johnson & Johnson plans to conduct a late-stage study of the company’s investigational vaccine for Human Immunodeficiency Virus (HIV) in several countries across the Americas and Europe, including the United States.
Germany’s Stada buys six of GSK’s consumer brands, eyes further deals
Stada said on Friday the private equity-backed company would buy six consumer healthcare products from British GlaxoSmithKline to bolster the generic drugmaker’s presence in Europe.
Medication-free treatment for depression launches in the UK
Flow, a medical device company, launched a medication-free treatment for depression comprising a brain stimulation headset and therapy app.
Rise of drug-resistant superbugs rings alarm bells in Europe
The spread of superbugs resistant to antimicrobial drugs shows no sign of slowing in Europe, health officials said, making food poisoning and other infections more difficult to treat.
New cases of HIV rise in Eastern Europe, decline in the West
More than 130,000 people were newly diagnosed with HIV last year in Eastern Europe – the highest rate ever for the region – while the number of new cases in Western Europe declined, global public health experts said.
Trump Signs FTC Law That Allows for Biosimilar Scrutiny
President Donald Trump signed a bill into law that requires pharmaceutical companies to provide details of biosimilar deals to the Federal Trade Commission for antitrust scrutiny.
Cancer deaths to rise to 9.6 million in 2018
Cancer will claim the lives of 9.6 million people in 2018, accounting for one in eight of all deaths among men and one in 11 among women, the WHO’s cancer research agency said.
Study sees dramatic rise in heatwave deaths by 2080
The number of people dying from heatwaves is likely to rise sharply in some regions by 2080 if policymakers fail to take mitigating steps in climate and health policies, according to the results of a study.
CRISPR Therapeutics Plans to Treat First Patients for Beta Thalassemia in Europe
CRISPR Therapeutics is ready to begin treating patients in Europe using the company’s CRISPR gene-editing tool. The plan is to treat patients with beta thalassemia, a blood disorder that decreases the production of hemoglobin, the iron-containing protein in red blood cells that carries oxygen.
Ad Right Top
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com. 
October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!